General application of the National Institute for Health and Clinical Excellence (NICE) guidance for active surveillance for men with prostate cancer is not appropriate in unscreened populations.
Matthew R
MR
Hotston
Hashim U
HU
Ahmed
Rajendra
R
Persad
D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000601:surgery*
D017430:Prostate-Specific Antigen